These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Diagnostic and Prognostic Role of 18-FDG PET/CT in the Management of Resectable Biliary Tract Cancer. Ma KW, Cheung TT, She WH, Chok KSH, Chan ACY, Dai WC, Chiu WH, Lo CM. World J Surg; 2018 Mar; 42(3):823-834. PubMed ID: 28905105 [Abstract] [Full Text] [Related]
50. 18F-FDG PET/CT can differentiate vertebral metastases from Schmorl's nodes by distribution characteristics of the 18F-FDG. Wang Z, Ma D, Yang J. Hell J Nucl Med; 2016 Mar; 19(3):241-244. PubMed ID: 27824963 [Abstract] [Full Text] [Related]
55. [Prognostic value of FDG-PET in Hodgkin lymphoma for posttreatment evaluation. Long-term follow-up results]. Molnár Z, Simon Z, Borbényi Z, Deák B, Galuska L, Keresztes K, Miltényi Z, Marton I, Rosta A, Schneider T, Trón L, Várady E, Illés A. Orv Hetil; 2009 Nov 22; 150(47):2133-8. PubMed ID: 19910278 [Abstract] [Full Text] [Related]
58. High (18)F-FDG uptake in urinary calculi on PET/CT: An unrecognized non-malignant accumulation. Fu Z, Li Z, Huang J, Zhang J, Liu M, Li Q, Li Y. Eur J Radiol; 2016 Aug 22; 85(8):1395-9. PubMed ID: 27423678 [Abstract] [Full Text] [Related]
60. Role of FDG PET-CT in the treatment management of Hodgkin lymphoma. Berriolo-Riedinger A, Becker S, Casasnovas O, Vander Borght T, Édeline V. Cancer Radiother; 2018 Sep 22; 22(5):393-400. PubMed ID: 30033076 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]